Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA-Sequencing of HepG2 cells treated with TGFBeta

ABSTRACT: RNA-Sequencing of HepG2 cells treated with TGFBeta

PROVIDER: PRJNA578102 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

RNA-Sequencing of HepG2 cells treated with TGFBeta

Project description:We report a subset of genes upregulated by TGFBeta after three hours of treatment

2019-10-18 | GSE139021 | GEO

cholangiocytes treated with TGFbeta

Project description:cholangiocytes treated with TGFbeta

| PRJNA606515 | ENA

Expression data from TGFbeta-treated control or aPKC silenced A549 cells

Project description:Aberrant TGFbeta signalling is a hallmark of epithelial derived tumours. Signalling patterns can depend on the membrane trafficking and internalization of the TGFbeta receptors. Protein kinase C (PKC), particularly the atypical PKC isoforms, alter the trafficking of TGFbeta receptors and can alter TGFbeta induced gene expression. We used microarrays to detail the programme of gene expression underlying TGFbeta induction between control or aPKC silenced A549 cells. Control or aPKC silenced A549 cells were serum starved and treated with TGFbeta for 1 hour. Total RNA was extracted from untreated or TGFbeta treated cells after 8 and 24 hours and analyzed using Affymetrix microarrays. We sought to assess TGFbeta gene expression in aPKC silenced lung cancer cells, as we found that knockdown of aPKC extends TGFbeta signalling as assessed by phospho Smad2 levels. Furthermore, increased expression and oncogenic activity of aPKC (PKCiota) has been reported in lung cancer cells.

2011-01-29 | E-GEOD-26241 | biostudies-arrayexpress

RNA-sequencing analysis of HepG2 cells treated with atorvastatin.

Project description: Not available

| S-EPMC4143339 | biostudies-literature

RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist

Project description:RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist

| PRJNA449680 | ENA

ChIP-seq of cholangiocytes treated with TGFbeta

Project description:ChIP-seq of cholangiocytes treated with TGFbeta

| PRJNA606517 | ENA

ATAC-seq of cholangiocytes treated with TGFbeta

Project description:ATAC-seq of cholangiocytes treated with TGFbeta

| PRJNA606518 | ENA

Expression data from TGFbeta-treated control or aPKC silenced A549 cells

2011-01-29 | GSE26241 | GEO

Human HepG2 cells: control DMSO vs. K7174-treated

Project description:Transcriptional profiling of human HepG2 cells comparing control DMSO-treated cells with K7174-treated cell Two-condition experiment, DMSO-HepG2 vs. K7174-HepG2 cells. Biological replicates: 1 control, 1 treated, independently grown and harvested. One replicate per array.

2014-08-01 | E-GEOD-48618 | biostudies-arrayexpress

RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist

Project description:We report differential expressed genes in HepG2 cells treated with control, E2, or an ER agonist

2018-12-10 | GSE112983 | GEO